loading

Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
19.40%
39.06
32.72 39.57 38.32 36.02
Operating Income/Loss
19.40%
-39.06
-32.72 -39.57 -38.32 -36.02
Nonoperating Income/Loss
0.44%
2.709
2.697 3.263 3.752 4.054
Income/Loss From Continuing Operations Before Tax
21.10%
-36.35
-30.02 -36.31 -34.57 -31.96
Income/Loss From Continuing Operations After Tax
21.10%
-36.35
-30.02 -36.31 -34.57 -31.96
Net Income/Loss
21.10%
-36.35
-30.02 -36.31 -34.57 -31.96
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.97%
78.13
71.04 0.3103 70.54 70.35
Diluted Average Shares
9.97%
78.13
71.04 0.3103 70.54 70.35
Basic Earnings Per Share
11.90%
-0.47
-0.42 -0.51 -0.49 -0.45
Diluted Earnings Per Share
11.90%
-0.47
-0.42 -0.51 -0.49 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):